DCLK1 Plays a Metastatic-Promoting Role in Human Breast Cancer Cells

الملخص EN

Background.

Doublecortin-like kinase 1 (DCLK1) has been universally identified as a cancer stem cell (CSC) marker and is found to be overexpressed in many types of cancers including breast cancer.

However, there is little data regarding the functional role of DCLK1 in breast cancer metastasis.

In the present study, we sought to investigate whether and how DCLK1 plays a metastatic-promoting role in human breast cancer cells.

Methods.

We used Crispr/Cas9 technology to knock out DCLK1 in breast cancer cell line BT474, which basically possesses DCLK1 at a higher level, and stably overexpressed DCLK1 in another breast cancer cell line, T47D, that basically expresses DCLK1 at a lower level.

We further analyzed the alterations of metastatic characteristics and the underlying mechanisms in these cells.

Results.

It was shown that, compared with the corresponding control cells, DCLK1 overexpression led to an increase in metastatic behaviors including enhanced migration and invasion of T47D cells.

By contrast, forced depletion of DCLK1 drastically inhibited these metastatic characteristics in BT474 cells.

Mechanistically, the epithelial-mesenchymal transition (EMT) program, which is critical for cancer metastasis, was prominently activated in DCLK1-overexpressing cancer cells, evidenced by a decrease in an epithelial marker ZO-1 and an enhancement in several mesenchymal markers including ZEB1 and Vimentin.

In addition, DCLK1 overexpression induced the ERK MAPK pathway, which resultantly enhanced the expression of MT1-MMP that is also involved in cancer metastasis.

Knockout of DCLK1 could reverse these events, further supporting a metastatic-promoting role for DCLK1.

Conclusions.

Collectively, our data suggested that DCLK1 overexpression may be responsible for the increased metastatic features in breast cancer cells.

Targeting DCLK1 may become a therapeutic option for breast cancer metastasis.